Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion) settlement to resolve tens of thousands of lawsuits in the US over its discontinued heartburn drug Zantac.
Home
Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion) settlement to resolve tens of thousands of lawsuits in the US over its discontinued heartburn drug Zantac.
Free Netflix and Sky TV trial deal ends in hours – here’s how to claim it
Private sector grows steadily in May amid signs of cooling services inflation
Net migration to UK drops after hitting record levels, fuelling election debate
Ten Hag saves United career or City win double? – FA Cup final talking points
This will close in 0 seconds